Ion Torrent PGM Sales Exceed Life Tech's Expectations in Q1 while SOLiD Sales Suffer | GenomeWeb

By Julia Karow

Life Technologies said last week that first-quarter revenues in its genetic systems division fell year-over-year as the Japanese earthquake delayed shipments of the 5500 SOLiD, fewer customers bought SOLiD 4 systems and reagents, and the capillary electrophoresis business declined compared to the previous year's exceptionally strong first quarter.

Sales of the Ion Torrent PGM, on the either hand, were larger than the company had anticipated for the quarter.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: RNA-seq, ChIP-seq to determine metformin response; array-based approach to detect protozoa in blood; and more.

Fast Company takes a look at startups in the nutrigenomic space that aim to offer personalized diet advice.

In a glamorous event, the Breakthrough Foundation gave out more than $25 million in prizes to researchers.

Immunotherapy might treat cancer, but it also appears to come with a risk of a number of side effects, the New York Times reports.